Nobody puts "renewal overhead" in the deal model. That's the problem.
When a rep closes a one-year agreement, finance marks it as won and moves on. The quota gets credited. The commission gets paid. The deal looks clean. What doesn't show up anywhere in that moment is the operating cost that just got scheduled for twelve months from now — the CS cycles to re-engage the account, the legal back-and-forth on updated terms, the executive time spent on a renewal conversation that should have been a non-event, the risk that a competitor gets a conversation they wouldn't have gotten inside a longer commitment. Do that across your book of business and you've built a recurring operating expense into your cost structure that nobody explicitly approved.
This is what John Wooden understood about preparation that most sales organizations still haven't internalized: doing something halfway and doing it over costs more than doing it right the first time. A one-year deal isn't a conservative choice. It's a deferred cost.
The CFO and CRO questions I hear most often — how do we use pricing and packaging to push contract duration, how do we align comp to reinforce that, and where does RevOps fit in all of it — are actually one question. The answer to all three is the same: pricing and packaging is an income statement decision, and RevOps is the function that makes it executable.
The Income Statement Argument for Contract Duration
Let's run the math that most companies don't run. A one-year agreement requires your organization to re-earn the customer's business every twelve months. That renewal cycle has real costs: customer success touches to prepare the account, legal review of contract terms, sales involvement if there's a competitive situation, finance time to process the change. Multiply that by your renewal count and you've got a headcount-driven operating cost that scales linearly with your customer base. It doesn't improve with volume. It just gets more expensive as you grow.
A two or three-year agreement doesn't eliminate that cost — it spreads it. The legal work, the executive conversation, the account review all happen once instead of annually. The same CS team covers more revenue. The same legal resources handle fewer cycles. That's operating leverage on the income statement, and it flows directly to EBITDA.
The RevOps charter, properly defined, is to grow enterprise value through operating leverage. Not to generate more pipeline. Not to produce more reports. To find the places in the revenue motion where the same effort produces more output — and contract duration is one of the clearest levers available. The irony is that most organizations treat it as a sales preference rather than a financial architecture decision. If the CFO and CRO are having this conversation together, they're having it in the right room. If it's happening only in sales, it's being solved for the wrong objective.
Three Levers. One Motion.
Getting contract duration right isn't a single decision — it's three interlocking ones. Pricing and packaging sets the structure. Compensation determines whether reps behave consistently with it. RevOps builds the guardrails that hold it together in the field. Pull only one and the other two drift.
Pricing and Packaging: Build the Incentive into the Structure
The pricing model should do some of the work. If a one-year and a three-year agreement are priced close to identically, you've already answered the question for the buyer — they'll take the shorter commitment every time. The packaging has to create a genuine value differential that makes the multi-year decision economically obvious, not just marginally better.
This doesn't mean discounting your way to longer deals. Deep discounts on multi-year TCV trade gross margin for duration and usually destroy the unit economics you were trying to protect. The better approach is to build multi-year value into the packaging itself — implementation support, expanded feature access, a named success resource, priority SLA tiers — so the longer commitment is worth more, not just cheaper. That decision lives at the intersection of product, marketing, and finance. RevOps doesn't own it, but RevOps assembles the inputs and runs the approval process to get it across the line.
Sales Compensation: Make the Income Statement the Rep's Objective
How you compensate your sales team is a direct expression of what you value. If your reps are paid identically on a one-year and a three-year deal of equivalent ACV, you've told them contract duration doesn't matter. They'll optimize for what closes fastest — which is almost always the shorter commitment.
Comp accelerators on multi-year TCV change that calculus. A rep who earns meaningfully more on a 36-month commitment than a 12-month one at equivalent annual value will fight for the longer deal. But the guardrail matters: if you put accelerators on TCV without tightening discount authority, you'll get reps pushing multi-year contracts at 35% discounts. You've extended duration and compressed margin simultaneously. The comp design and the pricing governance have to be built together, not in separate conversations that happen to reference each other.
The principal-agent problem here is real. Reps are rational actors responding to the incentive structure you gave them. If the structure rewards short-cycle, single-year closes, that's what you'll get — regardless of what the CRO asks for in the QBR. Comp is the mechanism that converts strategy into behavior. Design it deliberately or it designs your outcomes for you.
RevOps: The Guardrails That Hold It Together
This is where RevOps earns its seat at the table — not by owning the pricing strategy, but by operationalizing it. The difference between a pricing decision made in a planning meeting and a pricing discipline that shows up in every deal is the infrastructure RevOps builds around it.
That infrastructure includes discount approval thresholds that match the comp structure (so a rep can't earn an accelerator on a deal they discounted into unprofitability), contract term floors that align with the packaging value differential, and a deal approval workflow that creates the right friction at the right moments — not a bureaucratic bottleneck, but a governance layer that keeps field behavior consistent with the income statement objectives the CFO and CRO agreed to.
Deal governance done right isn't a tax on the sales team. It's what protects their comp plan from the deals that look good on paper and hurt the business in year two. RevOps is the function with the cross-functional visibility — into the pipeline, the comp model, the margin structure, and the forecast — to see when those deals are materializing and do something about it before they close.
Those two numbers come from the same operating philosophy applied to different parts of the revenue motion. The 30% velocity improvement happened when the organization got disciplined about who it was selling to — not chasing every opportunity in the funnel, but qualifying hard against the ICP and moving faster on the accounts that fit. The 67% gross profit growth happened when deal governance got operationalized — approval workflows, discount controls, contract term minimums that the field had to work within rather than around.
Neither outcome required hiring more people. Both required building the right infrastructure around the people already there. That's operating leverage. That's what shows up in EBITDA.
Who Owns This Conversation?
Here's the honest answer to the question most organizations avoid: nobody owns it, which is why it doesn't get resolved.
Pricing strategy should live with product, marketing, and finance — they hold the knowledge of what the product is worth, what the market will bear, and what the cost structure demands. Sales comp design belongs to the CRO and finance together, with RevOps modeling the behavioral and economic scenarios. Deal governance is a RevOps function. But all three conversations have to happen in coordination, not in sequence, and not in separate planning cycles that happen to share a spreadsheet.
The reason RevOps is positioned to lead the orchestration — not the strategy, the orchestration — is that RevOps is the only function with a line of sight across all three. The comp model affects the pricing model affects the deal approval thresholds affects the gross margin affects the EBITDA. RevOps can model that chain. RevOps can flag when the comp plan is working against the pricing architecture. RevOps can see the discount patterns in the deal data before they show up in the quarterly gross margin review.
"One man can be a crucial ingredient on a team, but one man cannot make a team."
— Kareem Abdul-JabbarThat's as clean a description of the RevOps role in pricing governance as I've heard. The function is an ingredient — a critical one — not the whole answer. A CRO who expects RevOps to solve the pricing problem without product, marketing, and finance in the room will be disappointed. A CFO who thinks pricing discipline happens automatically once comp accelerators are in place will be surprised when the discount rates don't move. The motion only works when it's genuinely coordinated.
If you're a CRO or CFO reading this and thinking "we've talked about contract duration for three planning cycles and nothing has changed" — that's the tell. The conversation is happening in the wrong room, with the wrong owner, or without the operating infrastructure to make the decision stick in the field. Getting those three things right is what turns a pricing strategy into a gross profit number.
Wooden had it right. Do it right the first time. Build the structure, align the comp, and put the guardrails in place — because the cost of doing it over compounds in ways that don't show up until it's too late to fix them cleanly.
